Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer Myriad Genetics, Inc.

… 10-year, prostate-specific mortality. Importantly, however, there were no observed prostate cancer-specific deaths over … RNA-expression test that directly measures tumor cell growth characteristics for stratifying … risk of disease-specific mortality in prostate cancer patients. Prolaris provides a quantitative …